celgeneremspharmacyportal.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title REMS PATIENT
Description Welcome to the REMS Programs Administered by Bristol Myers Squibb To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs
Keywords N/A
Server Information
WebSite celgeneremspharmacyportal faviconcelgeneremspharmacyportal.com
Host IP 45.60.150.161
Location United States
Related Websites
Site Rank
More to Explore
celgeneremspharmacyportal.com Valuation
US$6,758,595
Last updated: 2023-05-14 11:45:52

celgeneremspharmacyportal.com has Semrush global rank of 1,566,051. celgeneremspharmacyportal.com has an estimated worth of US$ 6,758,595, based on its estimated Ads revenue. celgeneremspharmacyportal.com receives approximately 779,838 unique visitors each day. Its web server is located in United States, with IP address 45.60.150.161. According to SiteAdvisor, celgeneremspharmacyportal.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,758,595
Daily Ads Revenue US$6,239
Monthly Ads Revenue US$187,162
Yearly Ads Revenue US$2,245,933
Daily Unique Visitors 51,990
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
celgeneremspharmacyportal.com. 28800 IN A IP: 45.60.150.161
celgeneremspharmacyportal.com. 28800 IN A IP: 45.60.170.161
celgeneremspharmacyportal.com. 28800 IN NS NS Record: ns3.bms.com.
celgeneremspharmacyportal.com. 28800 IN NS NS Record: ns4.bms.com.
celgeneremspharmacyportal.com. 28800 IN NS NS Record: ns1.bms.com.
celgeneremspharmacyportal.com. 28800 IN NS NS Record: ns2.bms.com.
celgeneremspharmacyportal.com. 28800 IN MX MX Record: 10 custmx.cscdns.net.
celgeneremspharmacyportal.com. 28800 IN TXT TXT Record: globalsign-domain-verification=91EE2763250C8EAD6A113B4AA3D1CBFD
celgeneremspharmacyportal.com. 28800 IN TXT TXT Record: p11wdkkkbjb8dd8q8jhr03dhvdzrfb6w
celgeneremspharmacyportal.com. 28800 IN TXT TXT Record: v=spf1 a ptr a:email.celgene.com -all
HtmlToTextCheckTime:2023-05-14 11:45:52
Welcome to the REMS Programs Administered by Bristol Myers Squibb To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the REMS products THALOMID ® (thalidomide), POMALYST ® (pomalidomide), REVLIMID ® (lenalidomide) and generic lenalidomide. The THALOMID REMS ® program, Lenalidomide REMS program and POMALYST REMS ® program require prescribers and pharmacists to be certified and patients to enroll and comply with all of the requirements for each program. If you would like to obtain more information about any of the Bristol Myers Squibb-administered REMS programs, please click on the program name below: Visit www.LenalidomideREMS.com , to learn more about the Lenalidomide REMS program. Visit www.POMALYSTREMS.com , to learn more about the POMALYST REMS ® program. Visit www.THALOMIDREMS.com , to learn more about the THALOMID REMS ® program. To complete a REMS related task, please select the appropriate option from below: Prescribers:
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://celgeneremspharmacyportal.com/
Content-Length: 0
Connection: close

HTTP/2 302 
location: /REMSPharmacyPortal/remspharmacy/portal/REMSPharmacyPortal.portal
cache-control: no-cache
pragma: no-cache
set-cookie: visid_incap_2668664=R3j/v8imRXCrWG5pBTWzhA46xGEAAAAAQUIPAAAAAAAQrcT2EX2hxxi8eGyT01aJ; expires=Fri, 23 Dec 2022 06:37:11 GMT; HttpOnly; path=/; Domain=.celgeneremspharmacyportal.com
set-cookie: incap_ses_1292_2668664=aChRTvgtqwmntqbHdhvuEQ46xGEAAAAAvIbm/b5ATZXg4o+CCl1wuQ==; path=/; Domain=.celgeneremspharmacyportal.com
x-cdn: Imperva
x-iinfo: 11-63625287-63625288 NNNN CT(28 57 0) RT(1640249870253 0) q(0 0 1 0) r(1 1) U6

HTTP/2 200 
cache-control: no-store
date: Thu, 23 Dec 2021 08:56:39 GMT
pragma: no-cache
content-type: text/html; charset=UTF-8
expires: Thu, 01 Jan 1970 00:00:00 GMT
x-frame-options: SAMEORIGIN
set-cookie: JSESSIONID=p5jmgbT-IWInQnep451zETnLI1MXL8ZQxL5f-_b9Ld5QKVSDL4dO!1770499310!699152808; path=/; secure; HttpOnly
set-cookie: NSC_JOro1ytqe53qvusblqrc1ad4eqxwuc3=ffffffffaf10130645525d5f4f58455e445a4a422d6a;path=/;secure;httponly
set-cookie: visid_incap_2668664=R3j/v8imRXCrWG5pBTWzhA46xGEAAAAAQUIPAAAAAAAQrcT2EX2hxxi8eGyT01aJ; expires=Fri, 23 Dec 2022 06:37:11 GMT; HttpOnly; path=/; Domain=.celgeneremspharmacyportal.com
set-cookie: incap_ses_1292_2668664=5oYAfHEGlW+ntqbHdhvuEQ46xGEAAAAALrouX+/zFibtuTf0b+11Dw==; path=/; Domain=.celgeneremspharmacyportal.com
x-cdn: Imperva
x-iinfo: 11-63625309-63625310 NNNN CT(28 28 0) RT(1640249870387 0) q(0 0 1 0) r(1 1) U6
celgeneremspharmacyportal.com Whois Information
Domain Name: CELGENEREMSPHARMACYPORTAL.COM
Registry Domain ID: 1787412647_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-03-15T05:16:14Z
Creation Date: 2013-03-19T13:08:48Z
Registry Expiry Date: 2022-03-19T13:08:48Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.BMS.COM
Name Server: NS2.BMS.COM
Name Server: NS3.BMS.COM
Name Server: NS4.BMS.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-26T07:46:51Z <<<